<DOC>
<DOCNO>
EP-0000656
</DOCNO>
<TEXT>
<DATE>
19790207
</DATE>
<IPC-CLASSIFICATIONS>
C07H-17/08 A61P-31/00 A61K-31/70 C07H-17/00 <main>C07H-17/08</main> A61K-31/7048 A61K-31/7042 A61P-31/04 
</IPC-CLASSIFICATIONS>
<TITLE>
4"-ureido-oleandomycin derivatives, process for their preparation and their use in pharmaceutical compositions.
</TITLE>
<APPLICANT>
pfizerus<sep>pfizer inc.<sep>pfizer inc.235 east 42nd streetnew york, n.y. 10017us<sep>pfizer inc.  <sep>
</APPLICANT>
<INVENTOR>
bright gene michael<sep>bright, gene michael<sep>bright, gene michaelapt. b 3-4 broad street extensiongroton new london connecticutus<sep>bright, gene michael<sep>bright, gene michaelapt. b 3-4 broad street extensiongroton new london connecticutus<sep>
</INVENTOR>
<ABSTRACT>
a compound of the formula:    wherein y is a group of the formula: -nhconhr₁,    -n = c = o or -nhcn; r is alkanoyl having two or three carbon  atoms; r₁ is hydrogen, pyridylmethyl, furylmethyl,  thenyl, hydroxypyridyl, phenyl, benzyl, or phenyl or benzyl  substituted by methyl, chloro, fluoro, methoxy, amino or trifluoromethyl;  and x is methyl, methoxy, fluoro, chloro or  trifluoromethyl; or a pharmaceutically acceptable acid addition  salt thereof when y is other than -n = c = o.  a process for preparing these compounds and pharmaceutical  compositions containing them.  
</ABSTRACT>
</TEXT>
</DOC>
